mt-Nd2 and Resistance to Autoimmune Diabetes
mt-Nd2 与自身免疫性糖尿病的抵抗力
基本信息
- 批准号:8475461
- 负责人:
- 金额:$ 30.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:ALR MouseAccountingAllelesAlloxanAmino AcidsAntigen TargetingApoptoticAttentionAutoimmune DiabetesAutoimmune ProcessBeta CellBiological AssayBlood PressureBreedingCD8-Positive T-LymphocytesCD8B1 geneCandidate Disease GeneCell DeathCell Death Signaling ProcessCell LineCell NucleusCell physiologyCell-Mediated CytolysisCellsCessation of lifeCollectionCommunicationComplexCytochrome c ReductaseCytolysisCytotoxic T-LymphocytesDataDevelopmentDiabetes MellitusEngraftmentFigs - dietaryFutureGenerationsGenesGeneticGenetic PolymorphismGenetic Predisposition to DiseaseGenetic VariationGenomicsGlucoseGoalsGranzymeHumanHuman CharacteristicsImmuneImmune systemIn VitroInbred NOD MiceIndividualInjuryInsulinInsulin-Dependent Diabetes MellitusIslet CellIslets of LangerhansIslets of Langerhans TransplantationKnowledgeLeadLeucineLifeLigationLinkLongevityMediatingMembrane PotentialsMetabolismMitochondriaMitochondrial DNAMouse StrainsMusMutationMyocardial InfarctionNon-Insulin-Dependent Diabetes MellitusNuclearOxidative StressPancreasPathogenesisPathologyPathway interactionsPatientsPlayPopulationPredispositionProductionProtocols documentationReactive Oxygen SpeciesReportingResearchResearch DesignResistanceRiskRoleSignal TransductionSingle Nucleotide PolymorphismSourceStressT-LymphocyteTNF geneTNFRSF1A geneTestingTissuesTransplantationTumor Necrosis Factor ReceptorVariantVisualWorkatherogenesisattenuationcellular engineeringcohortcytokinefree radical oxygenfunctional disabilitygenetic analysisgenetic elementgenetic pedigreegenetic variantglucose toleranceimprovedinsightinsulin secretionisletkillingsmembermitochondrial DNA mutationmouse modelperforinpreventreceptorresistance mechanismstemtherapeutic targetward
项目摘要
DESCRIPTION (provided by applicant): Mitochondria (mt) play key roles in cellular energy production and cell death. Beta cell function is tightly linked to mitochondria; as both insulin synthesis and glucose stimulated insulin secretion require mitochondrial ATP production. In this context, reports of mitochondrial DNA (mtDNA) mutations associated with diabetes (T2D) pedigrees in humans account for up to 1% of human T2D. However, mutations in mtDNA are not commonly associated with autoimmune Type 1 diabetes (T1D), although a C to A transversion resulting in a leucine to methonine substitution in the mt-ND2 gene has been associated with protection from T1D in both an at risk human population and in crosses of the T1D-prone NOD with T1D-resistant ALR mice. The goal of this application is to understand how this single amino acid change modifies resistance to T1D. Genetic analysis of T1D susceptibility has focused attention on candidate genes controlling aberrant immune cell function with little focus on genes that may contribute susceptibility or resistance at the ¿ cell level. Pancreatic islets from the ALR mouse strain maintain an unusual genetic resistance to functional impairment and killing by autoimmune effectors. Our results have linked some of the ALR-derived T1D resistance to mt- Nd2a. While this allele does not prevent the development of spontaneous T1D when introgressed into the NOD genetic background, the ALR-derived genetic variant does in fact protect beta cells from destruction by cytotoxic T lymphocytes as well as combined cytokines. We have determined that this resistance stems from the inability of pro-apoptotic stress to induce mt reactive oxygen species. Our goal is to understand the role this gene plays in ¿ cell resistance to autoimmune killing. In specific aim 1 we will determine the
mechanism by which mt-Nd2a encoding ¿ cells and primary islets resist destruction mediated by members of the Tumor Necrosis Factor Receptor family, TNFR1 and Fas. Aim 2 will extend the studies to determine the mechanisms utilized by mt-Nd2a encoding islet cells to avert lysis by CTL. Specific aim 3 will use human islets to confirm mechanisms of resistance to ¿ cell destruction as well as cybrid human ¿ cells to test if the human alleles of mt-ND2 alter the characteristics of human ¿ cell death. The studies, as proposed, will provide meaningful data on both the early apoptotic signals that result in human beta cell death as well as insights into how ND2a protects human beta cells.
描述(由适用提供):线粒体(MT)在细胞能量产生和细胞死亡中起关键作用。 β细胞功能与线粒体紧密相关。由于胰岛素合成和葡萄糖刺激的胰岛素分泌都需要线粒体ATP产生。在这种情况下,人类中与糖尿病(T2D)血统有关的线粒体DNA(mtDNA)突变的报告最多占人类T2D的1%。然而,mtDNA中的突变通常与自身免疫性1型糖尿病(T1D)无关,尽管A c to tress to t tertrose的c导致MT-ND2基因中的亮氨酸替代亮氨酸与t1d人群中的T1D均与T1D cross and T1d-prone nod nod Nod contert and a t1d-nod Nod a a t1d-al a al a al a al a al a al a al a al a al a al a al a ail mice均与T1D的保护有关。该应用的目的是了解这种单个氨基酸改变修饰符对T1D的抗性。 T1D敏感性的遗传分析将注意力集中在控制异常免疫核管功能的候选基因上,而几乎没有关注可能在细胞水平上有助于敏感性或抗性的基因。 ALR小鼠菌株的胰岛保持了对功能障碍和自身免疫性效应杀死的异常遗传抗性。我们的结果已将ALR衍生的T1D抗性与MT-ND2A联系起来。尽管该等位基因并不能阻止在浸入点头遗传背景时发育T1D的发展,但实际上,ALR衍生的遗传变异确实可以保护β细胞免受细胞毒性T淋巴细胞以及结合细胞因子的破坏。我们已经确定,这种抗性阶段源于促凋亡应激无法诱导MT活性氧。我们的目标是了解该基因在自身免疫性杀死的细胞耐药性中的作用。在特定目标1中,我们将确定
MT-ND2A编码细胞和原代胰岛抵抗由肿瘤坏死因子受体家族TNFR1和FAS介导的破坏的机制。 AIM 2将扩展研究,以确定MT-ND2A编码胰岛细胞使用的机制,以避免CTL裂解。具体目标3将使用人类胰岛来确认对细胞破坏的抗性机制以及cybrid人»细胞,以测试MT-ND2的人类等位基因是否改变了人类细胞死亡的特征。据提出,这些研究将提供有意义的数据,这些数据对早期的凋亡信号,这些信号导致人β细胞死亡以及对ND2A如何保护人β细胞的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAYTON E MATHEWS其他文献
CLAYTON E MATHEWS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAYTON E MATHEWS', 18)}}的其他基金
Discovery and Roles of In Situ Islet Neoantigens in Human Type 1 Diabetes
原位胰岛新抗原在人类 1 型糖尿病中的发现及其作用
- 批准号:
10589578 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
- 批准号:
10903049 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
- 批准号:
10417267 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
Multi-omic 3D tissue maps for a Human BioMolecular Atlas
人类生物分子图谱的多组学 3D 组织图谱
- 批准号:
10649957 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
Determining the mechanism of IFIH1 disease-associated variants on beta-cell and immune responses in Type 1 diabetes
确定 1 型糖尿病中 IFIH1 疾病相关变异对 β 细胞和免疫反应的机制
- 批准号:
10263321 - 财政年份:2020
- 资助金额:
$ 30.33万 - 项目类别:
Genetic Regulation of Human Beta Cell Destruction
人类β细胞破坏的基因调控
- 批准号:
8813679 - 财政年份:2014
- 资助金额:
$ 30.33万 - 项目类别:
mt-Nd2 and Resistance to Autoimmune Diabetes
mt-Nd2 与自身免疫性糖尿病的抵抗力
- 批准号:
7998873 - 财政年份:2010
- 资助金额:
$ 30.33万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
- 批准号:
10709381 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Popliteal Pterygium syndrome, IRf6, and the periderm
腘胬肉综合征、IRf6 和周皮
- 批准号:
10727050 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
Decoding the Paradox of DDX41-mutant MDS
解读 DDX41 突变型 MDS 的悖论
- 批准号:
10905168 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别:
The role of non-coding variants in Usher disease
非编码变异在亚瑟病中的作用
- 批准号:
10588508 - 财政年份:2023
- 资助金额:
$ 30.33万 - 项目类别: